Search Results 791-800 of 18398 for Hepatitis b

  1. A Study to Assess the Effectiveness and Safety of Ublituximab in combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

    Evidence of chronic active Hepatitis B (HBV) infection as evidenced by a detectable hepatitis B surface antigen (HBsAg) (not including subjects with prior ...

  2. A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation - Mayo Clinic

    ... hepatitis B or C. Patients with a history of hepatitis B vaccination without history of hepatitis B are allowed to enroll; A history of known ...

  3. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy - Mayo Clinic

    Participation eligibility · Documentation of HBsAg, hepatitis B surface antibody (HBsAb), hepatitis B core antibody (HBcAb), and hepatitis C virus (HCV) antibody ...

  4. A Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis - Mayo Clinic

    Current hepatitis B infection (defined as positive for hepatitis B surface antigen [HBsAg] and/or hepatitis B core antibody [HBcAb]). Subjects with ...

  5. 4/16/16 #MayoClinicRadio Podcast: Hep C, Food Allergies, Hemorrhoids - Mayo Clinic News Network

    On Mayo Clinic Radio, infectious diseases specialist Dr. Stacey Rizza outlines the risk factors for contracting hepatitis C, especially for people born between ...

  6. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    Active hepatitis B or C with uncontrolled disease;. Note: a detailed assessment of Hepatitis B/C medical history and risk factors must be done at screening ...

  7. Adalimumab-afzb (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Granulomatosis polyangiitis—Use with caution. May increase the chance of getting new cancers. Diabetes or; Hepatitis B, history of or; Opportunistic infections, ...

  8. A Study to Evaluate the Effectiveness, Safety, and Tolerability of TAK-935 as an Adjunctive Therapy in Pediatric Patients with Developmental and/or Epileptic Encephalopathies - Mayo Clinic

    ... hepatitis B, or active hepatitis C infection. (Note that patients who have been vaccinated against hepatitis B [hepatitis B surface antibody {Ab}-positive] ...

  9. Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia - Mayo Clinic

    Subjects with hepatitis B core antibody positive who are surface antigen ... Those who are hepatitis B surface antigen positive or hepatitis B PCR ...

  10. Amphotericin b lipid complex (intravenous route, injection route) - Side effects & dosage - Mayo Clinic

    Description. Amphotericin B lipid complex is an antifungal medicine. It is used to help the body overcome serious infections caused by fungus. This medicine is ...